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Patients with atopic dermatitis react to various
stimuli with vasoconstriction of the cutaneous
vessels (1—3). The cause of their increased vascu-
lar contractility is nnknown. One explanation
could be an increased sensitivity to epinephrine
or norepinephrine. Lobitz and Campbell (2)
found normal reactions to intracutaneously in-
jected epinephrine in ten patients with atopic
dermatitis; however, they did not ascertain
whether the minimum dose needed to cause
blanching was different in normal subj eets and
patients with atopic dermatitis.
The following investigation was therefore per-
formed to study the blanching reaction to
epinephrine and l-norepinephrine administered
by a quantitative iontophoretic method into the
non-diseased skin areas of normals and patients
with atopic dermatitis, eczema and psoriasis.
METHODs
lontophoretic Apparatus: The anodes of
platinum (0.64 em2. each) from which positively
charged substances are introduced into the skin
are arranged in twelve equal-sized and separate
cylindrical chambers, mounted in a plexi-glass
block. They thus make a multi-electrode unit
(Fig. la and b). The discs of platinum are mounted
1 cm above the skin surface. Each chamber re-
ceives its own amperage. In chamber No. 1, this
is 40 pA; this increases in equal percentual steps
(see fig. 3) towards chamber No. 11, where the
value is 1280 MA. Chamber No. 0 received no
current at all and is a control. The different
electrodes are arranged (Fig. 1) in order to avoid
interference between the electrodes. The control
electrode (No. 0) is near those with the highest
currents (No. 11 and 10).
To avoid the influence of variations in skin
resistance, resistances from 0.22 to 7.2 MQ (mega-
ohms) were connected to the anodes (ri—rn, fig. 2).
A constant voltage of 315 V was used. The resis-
tance of the body under the electrode (rb in Mu)
was calculated: ro = (312/i)—r, where i is the
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current through the chamber in pA and r, the
series-resistance (in Mu) connected to this anode
(fig. 2). The resistances r1—r0 were checked by
measuring the currents il—in without patient
(short connection 1—11 with C in fig. 2). The
following values in Mu were fonnd for r1—r11:
= 7.20 r = 2.66 r9 = 0.45
= 6.37 ri = 1.83 r10 = 0.33
= 5.28 r7 = 1.28 rn = 0.22
= 3.71 ri = 0.92 ro
The resistance of the body under the electrode
for each amperage is shown in fig. 3. Here it
becomes evident that the resistance of the body
under the electrode is between 5.5 and 10.9% of
the series resistance connected with the anode.
Changes in body resistance are therefore negligi-
ble. The stripping experiment described below
also illustrates this fact.
Experimental Procedure: The flexor aspect of
the forearm was washed with water, dried, and
the multielectrode fastened with rubber bands
about 7—17 cm below the antecubital fossa. The
cathode, a 6.3 x 6.3 cm brass plate, was fastened
on the opposite arm. An electrode ointment con-
taining 10 per cent NaCI was applied between the
skin and brass plate. The multieleetrode chambers
were then filled with the solution to be tested.
Electrode current was used for 30 seconds and the
anode removed. Under those anodes, wbere the
current had been great enough, the reaction to
epinephrine and norepinephrine consisted of
round, sharply limited, blanched spots (0.78 cm2)
with or without piloerection. The minimal dose
causing reaction could thus be determined. The
control anode without current never showed any
reaction. The reactions were maximal after about
four minutes and usually declined after ten to
twenty minutes, beginning in areas having re-
ceived the lower currents. The skin reaction noted
five minutes after cessation of the current has
been utilized in the following portion of these
experiments. All experiments were made at room
temperature (20—22° C.)
CONTROL EXPERIMENTS
Drug Concentration: The influence of concen-
tration of the epinephrine and norepinephrine has
been tested in 10 normal subjects and 5 patients
with atopic dermatitis. Each patient was tested
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Fm. la and b. The anode consists of a multi-electrode unit
with four different concentrations. Within a
concentration of 10 to 500 g/ml of the drugs,
similar reactions in the skin were observed. This
means that the drugs are introduced by electro-
phorctic mobility (iontophoresis) and not by
electroosmosis, i.e. carried passively with the
electroosmotic flow of fluid.
In the following experiments, 100 g/ml of
epinephrine or l-norepinephrine bitartrate dis-
solved in freshly prepared columnar distilled water
were used. The epinephrine was prepared from a
stock solution containing 1 mg epinephrine/ml
(Exadrin, Astra Sodertalje, Sweden).
Size and Place of Brass Electrode: The influence
of the contact area of the negative brass electrode
on reactions of the skin was studied by using three
different sizes (20, 40 and 80 cm2). The reactions
to epinephrine and norepinephrine at the anode
were found to be independent of the cathode size
used. The current through each chamber was also
controlled and found to be independent of the
cathode size used. Therefore, differences in con-
tact area at the cathode are of no importance.
In the following studies, the middle-sized brass
electrode has been used. The site of the cathode
Brass
electrode
FIG. 2. Diagram of the iontophoretic circuit
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FIG. 3. The electrode resistance of the body at
different amperages. Ordinate: Resistance of the
body in kiloohms. Abscissa: Current (pA) through
the chambers when the subject is tested.
on the body was found not to influence the skin
response. The currents through the chambers
were the same with the brass cathode placed on
the legs or on the same or opposite arm as the
anode.
Skin Thickness: The influence of the thickness
of the corneal layer was tested in 21 subjects
where the stratum corneum had been partly
removed by applying adhesive tape 18 times, 15
minutes, 1, 4, 24 or 48 hours before the ionto-
phoretic test. Comparison was made between the
response to norepinephrine on the stripped area
and the corresponding normal area on the other
arm. The quotients between the doses (currents)
needed to give a blanching response on stripped
skin/unstripped skin are as follows:
15 minutes 0.13; 0.33; 0.50; 0.50
1 hour 0.13; 0.25; 0.33; 0.75
4 hours 0.33; 0.33; 0.50; 0.50
24 hours 0.25; 0.50; 1.00; 2.00; 3.00
48 hours 0.25; 1.00; 1.00; 1.50
In most of the subjects stripped 15 minutes to
4 hours before iontophoresis, the blanching area
was not sharply limited to the area in contact
with the anode solution, but a fading out of the
blanching could be seen some minutes after
iontophoresis. This was probably due to edema
caused by the stripping. In unstripped skin, the
blanching area is always sharply limited to the
round anode area. No certain effect of stripping
was found on the pilomotor activity.
The currents through each chamber were
measured in some of the patients on the stripped
skin and were found to be the same as on the
unstripped skin. The increased response in
stripped skin induced by norepinephrine is thus
not due to a change in body resistance. It is
probably due to decreased retention of the sub-
stance in the superficial skin layer, which will be
discussed later.
MATEEIAL
The test site consisted of grossly normal forearm
skin in healthy medical students (age 19—24), and
patients with the following clinical entities: 1)
atopic dermatitis, 2) psoriasis, 3) various eczemas
(including seborrheic dermatitis, nummular
eczema, stasis dermatitis and non-specific hand
eczemas). It should be emphasized that only
grossly normal skin was utilized, unless otherwise
noted.
EESULTS
The minimum dose of epinephrine and nor-
epinephnne causing blanching and pilomotion in
pA
FIG. 4. The effect of iontophoretically intro-
duced norepinephrine. Ordinate: Per cent of the
subjects tested showing blanching and pilomotion.
Abscissa: Minimal current (= dose) in pA causingblanching and pilomotion. •——. Normal (17
subjects), X———X Eczema (40 subjects), •
Psoriasis (11 subjects), O—---C Atopic der-
matitis (22 subjects).
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FIG. 5. The effect of iontophoretically intro-
duced epinephrinc. Ordinate: Per cent of the
subjects tested showing blanching and pilomotion.
Abscissa: Minimal current (=dose) in jzA causing
blanching and pilomotion. •—-—. Normal (10
subjects), X—---X Eczema (23 subjects), •
Psoriasis (14 subjects), O—O Atopic dermatitis
(12 subjects).
the skin appears in figures 4 and 5. It is concluded
that decreased doses (=currents) of epinephrine
and norepinephrine produce blanching in atopie
dermatitis as compared with psoriasis (P c 0.05
resp. 0.01), eczema (P < 0.02), and controls
(P .c 0.01). No difference was found in the dose
causing piloerection nor in the reaction to epi-
nephrine or norepinephrine in diseased and
normal-appearing skin areas in 5 patients with
atopic dermatitis.
The patients reported did not receive systemic
corticosteroids or local therapy in the test area.
Four patients with atopic dermatitis received
0.5 mg. dexamethasone (Decadron, Merck,
Sharpe and Dobme) 4 times daily. Their skin
condition improved; when re-tested one week
hence, the results were identical.
DISCUSSION
An increased reaction to epincphrine and nor-
epinephrine was evidenced in patients with
atopic dermatitis. Lobitz and Campbell (2) and
Reed and Kierland (4) however, found normal
response in atopic patients to intradermally
injected epinephrine in dilution of 1/10,000 and
1/100,000. The discrepancy might be explained
by their use of comparatively high doses, so that
they obtained a blanching in all subjects. Since
they obtained blanching in all subjects, their
high doses of cpincphrine obliterated finer quan-
titative comparisons. It should be emphasized
that the results of iontophoresis and intradermal
injectiuns are not directly comparable; for intra-
dermal injection induces not clearly defined vari-
ables such as spreading and resorption.
Since patients with atopic dermatitis tested
with distilled water, saline, 48/80 or mecholyl at
currents lower than 160 MA do not develop
blanching, the lower currents themselves could
hardly produce the increased reactions noted with
epinephrine above. Nor can difference in skin
thickness explain the results. On the contrary, the
increased skin thickness seen in atopic dermatitis
might tend to mask even a more increased sensi-
tivity to epinephrine and norepinephrinc.
In atopic dermatitis the presence of edema has
been suggested in the unaffected skin (5, 6),
though no increased amount of water has been
demonstrated (7). Therefore, epinephrine intro-
duced in such edematous sites may be diluted and
resorbed rather than bound to the cells. Con-
versely, it might be assumed that epinephrine is
bound to the cells in normals, therefore, it is not
available to produce blanching to the same extent
as in atopic subjects. This was indeed the case,
as will be seen in the following paper. How-
ever, the finding of a normal pilomotor reaction
in atopic patients indicates that it is the vessels
which are more sensitive. We can, therefore, at
the present time not state whether the increased
blanching reaction found in patients with atopic
dermatitis is due to an increased sensitivity of the
vessels and/or a decreased binding of the drugs
to the cells which they have to pass before reach-
ing the effector organ. Each or both possibilities
might be valid as an explanation for the increased
tendency to vascular contractibility in atopic
dermatitis.
sUMMARY
Epinephrine and norcpinephrinc have been
introduced into the skin by a quantitative
iontophorctic method. The dose of the drug is
dependent on the current applied but independent
of body resistance and concentration used. The
minimum current applied for 30 seconds (=dose)
causing pilomotion and blanching has been esti-
mated in normals and in normal-appearing skiu
of patients with eczema, psoriasis and atopic
dermatitis. No difference was found in the pilo-
40 80 160 320 640 1280
pA
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motor reaction in the different diseases. A lower
threshold for blanching after both epinephrinc
and norepinephrine was found in patients with
atopic dermatitis. The mechanism for this in-
creased reaction is discussed.
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